BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2634350)

  • 21. Uncertainties in the mechanism of thiamin pyrophosphate-dependent alpha-keto acid dehydrogenase complexes.
    Nutr Rev; 1984 Sep; 42(9):328-30. PubMed ID: 6504412
    [No Abstract]   [Full Text] [Related]  

  • 22. Branched-chain ketoacid dehydrogenase activity and growth of normal and mutant human fibroblasts: the effect of branched-chain amino acid concentration in culture medium.
    Danner DJ; Priest JH
    Biochem Genet; 1983 Oct; 21(9-10):895-905. PubMed ID: 6661177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting E3 component of alpha-keto acid dehydrogenase complexes.
    Johnson MT; Yang HS; Patel MS
    Methods Enzymol; 2000; 324():465-76. PubMed ID: 10989453
    [No Abstract]   [Full Text] [Related]  

  • 24. Inborn errors of pyruvate metabolism.
    Robinson BH
    Biochem Soc Trans; 1983 Dec; 11(6):623-6. PubMed ID: 6421637
    [No Abstract]   [Full Text] [Related]  

  • 25. Alpha-keto acid dehydrogenase complexes: nutrient control, gene regulation and genetic defects. Overview.
    Patel MS; Harris RA
    J Nutr; 1995 Jun; 125(6 Suppl):1744S-1745S. PubMed ID: 7782938
    [No Abstract]   [Full Text] [Related]  

  • 26. Cloning of genes for branched-chain keto acid dehydrogenase in Pseudomonas putida.
    Sykes PJ; Sokatch JR
    Methods Enzymol; 1988; 166():350-9. PubMed ID: 3071713
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosis and mutational analysis of maple syrup urine disease using cell cultures.
    Chuang JL; Chuang DT
    Methods Enzymol; 2000; 324():413-23. PubMed ID: 10989449
    [No Abstract]   [Full Text] [Related]  

  • 28. Low activity of branched-chain alpha-keto acid dehydrogenase complex in human liver.
    Nonami T; Taniguchi K; Kurokawa T; Kasai Y; Takagi H; Sugiyama S; Shimomura Y; Hutson SM
    Am J Clin Nutr; 1995 Nov; 62(5):1023. PubMed ID: 7572728
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.
    Chuang JL; Davie JR; Chinsky JM; Wynn RM; Cox RP; Chuang DT
    J Clin Invest; 1995 Mar; 95(3):954-63. PubMed ID: 7883996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids.
    Jouvet P; Kozma M; Mehmet H
    Ann N Y Acad Sci; 2000; 926():116-21. PubMed ID: 11193026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Branched-chain keto acid dehydrogenase of yeast.
    Dickinson JR
    Methods Enzymol; 2000; 324():389-98. PubMed ID: 10989447
    [No Abstract]   [Full Text] [Related]  

  • 32. The 2-oxo acid dehydrogenase complexes: recent advances.
    Yeaman SJ
    Biochem J; 1989 Feb; 257(3):625-32. PubMed ID: 2649080
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipoate addition to acyltransferases of alpha-keto acid dehydrogenase complexes and H-protein of glycine cleavage system.
    Fujiwara K; Okamura-Ikeda K; Motokawa Y
    Methods Enzymol; 1997; 279():184-93. PubMed ID: 9211270
    [No Abstract]   [Full Text] [Related]  

  • 34. Dehydrogenases of alpha-keto acids: essential groups of the active centers.
    Severin SE; Khailova LS; Gomazkova VS
    Adv Enzyme Regul; 1986; 25():347-75. PubMed ID: 3812084
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulation of the alpha-keto acid dehydrogenase complexes and their involvement in primary biliary cirrhosis.
    Yeaman SJ; Bassendine MF; Fittes D; Hodgson DR; Heseltine L; Brown HJ; Mutimer DJ; James OF; Fussey SP
    Ann N Y Acad Sci; 1989; 573():183-91. PubMed ID: 2634346
    [No Abstract]   [Full Text] [Related]  

  • 36. 2-Oxo acid dehydrogenase complexes of multicellular organisms.
    Bunik VI
    Eur J Biochem; 2003 Mar; 270(6):1035. PubMed ID: 12631262
    [No Abstract]   [Full Text] [Related]  

  • 37. Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects.
    Chuang DT; Niu WL; Cox RP
    Biochem J; 1981 Oct; 200(1):59-67. PubMed ID: 6895847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
    Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
    J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of expression of branched-chain alpha-keto acid dehydrogenase subunits in permanent cell lines.
    Chinsky JM; Costeas PA
    Methods Enzymol; 2000; 324():479-90. PubMed ID: 10989454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Branched-chain alpha-keto acid dehydrogenase complex in rat skeletal muscle: regulation of the activity and gene expression by nutrition and physical exercise.
    Shimomura Y; Fujii H; Suzuki M; Murakami T; Fujitsuka N; Nakai N
    J Nutr; 1995 Jun; 125(6 Suppl):1762S-1765S. PubMed ID: 7782942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.